Hyderabad-based Indian Immunologicals Limited (IIL) has partnered with Australia’s Griffith University to develop the COVID-19 vaccine. Scientists from IIL and Griffith University will jointly develop a “live attenuated SARS – CoV-2 vaccine” or COVID-19 vaccine using the “latest codon de-optimization technology”.
Click Here To Get Test Series For SBI PO 2020
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization. Upon the completion of the research, the vaccine strain will be transferred to ILL. It will work with the Central Drugs Standard Control Organisation (CDSCO), to conduct clinical trials. IIL intends to use its Vero cell platform tech for mass production of the vaccine.
What is Indian Immunologicals Limited?
Indian Immunologicals Limited is a major player in the human vaccine market in the country, supplying human pediatric and rabies vaccines. IIL is also a major supplier of pediatric vaccines to the country’s state-run universal immunization programme. IIL is promoted by the National Dairy Development Board. It is committed to addressing critical public health needs by engaging in this collaboration.
Important takeaways for all competitive exams:
Adda247, India’s leading platform for government exam preparation, has teamed up with Mangalayatan University, one…
Rafael Nadal, one of tennis's all-time greats, bid farewell to professional tennis at the 2024…
India is all set to host the inaugural Kho Kho World Cup from January 13…
In the July-September 2024 quarter, India's urban unemployment rate decreased to 6.4%, marking the lowest…
The Indian Army successfully conducted the "Sanyukt Vimochan 2024," a Multilateral Annual Joint Humanitarian Assistance…
The state of Uttar Pradesh, known for its rich history and culture, is home to…